Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics.

@article{Groot2009ReducingRI,
  title={Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics.},
  author={Anne S De Groot and William Martin},
  journal={Clinical immunology},
  year={2009},
  volume={131 2},
  pages={189-201}
}
One of the great surprises of the biologics revolution has been the discovery that recombinant human proteins, including monoclonals of human origin, can cause immune responses when administered to immune-competent subjects. Preclinical and clinical evaluations of the potential immunogenicity of biologics have been primarily focused on humoral immune responses and as a result, the critical contribution of T cells to the development of anti-monoclonal antibodies (also known as anti-drug… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 82 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 49 references

B

  • Q. Zhang, P. Wang, +13 authors Z. Zhu
  • 200 A.S. De Groot, W. Martin Peters, Immune…
  • 2008

Clinical Validation of in silico prediction of Immunogenicity of a Recombinant Therapeutic Protein. Presentation at the 2nd Protein Therapeutics Discovery and Development conference

  • Jawa, Vibha
  • Sept 7–8,
  • 2008
1 Excerpt

EpiMatrix: Tool for Accelerated Epitope Selection and Vaccine Design

  • M. Ardito, A. S. De Groot, J. A. McMurry, L. Moise, W. Yang, W. Martin
  • Poster Presenatation, 2nd Annual Vaccine…
  • 2008
2 Excerpts

Immunogenicity screening using in silico methods: correlation between T-cell epitope content and clinical immunogenicity of monoclonal antibodies

  • S. Hai, J. A. McMurry, P. Knopf, W. Martin, A. S. De Groot
  • Therapeutic Antibodies: from Theory to Practice…
  • 2008
1 Excerpt

P

  • A. S. De Groot, L. Moise, J. A. McMurry, E. Wambre, L. Van Overvelt
  • Moingeon,W. Scott,W.Martin, Activation of natural…
  • 2008
2 Excerpts

Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein

  • E. Koren, A. S. De Groot, +9 authors W. Martin
  • Clin. Immunol. 124 (1)
  • 2007
1 Excerpt

Development of a maturing T - cell - mediated immune response in patients with idiopathic Parkinson ' s disease receiving r - metHuGDNF via continuous intraputaminal infusion

  • Vibha Jawa, A. K. Abbas
  • J . Clin . Immunol .
  • 2007

Similar Papers

Loading similar papers…